Several
selenocysteine Se-conjugates (SeCys-conjugates) prevent against chemically induced
carcinogenesis. Bioactivation to selenols (RSeH) by beta-
lyases is thought to be critical, but the mechanism of
tumor suppression remains unclear. Induction of phase II biotransformation
enzymes is a possible mechanism of
chemoprevention. In this study, we evaluated the
isoform-selective induction of
glutathione-S-transferase (GST) at the
mRNA level using a quantitative
reverse transcriptase polymerase chain reaction assay. In cultured primary rat hepatocytes and H35 Reuber rat
hepatoma cells, SeCys-conjugates time-dependently increased
mRNA levels of
GST Alpha isoforms and GST Pi, but not of GST Mu
isoforms. Se-allyl-L-
selenocysteine, the most potent chemopreventive SeCys-conjugate so far known, was also the most active GST inducer. After exposure for 24hr, it elevated GSTA2, GSTA3, GSTA5, and GSTP
mRNA levels in primary hepatocytes 3.2+/-0.4-, 1.9+/-0.1-, 4.3+/-0.3-, and 2.9+/-0.3-fold, respectively. Se-allyl-D-
selenocysteine was significantly less active, suggesting that stereoselective conversion of SeCys-conjugates to selenols is involved in GST induction. In H35 Reuber
hepatoma cells, where conversion of SeCys-conjugates to selenols was 2-6-fold lower than in primary hepatocytes, GST induction was also much lower than in primary hepatocytes. SeCys-conjugates did not induce
cytochrome P450 1A1, 2B1/2, or 3A1. This indicates that SeCys-conjugates are monofunctional inducers of phase II biotransformation
enzymes. The present results suggest that induction of GST expression contributes to the chemopreventive activity of SeCys-conjugates.